|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1997-2-4
|
|
pubmed:abstractText |
HCV infection is a major complication among patients undergoing dialysis therapy throughout the world. In the years prior to the use of human recombinant erythropoietin (rHuEpo), patients undergoing haemodialysis were subjected to an excessive iron load as a consequence of frequent blood transfusions. Recent data in the non-dialysis population have shown a positive correlation between iron deposits and the severity of HCV hepatitis and between iron deposition and an impaired response to interferon therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0931-0509
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1792-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8918624-Aged,
pubmed-meshheading:8918624-Alanine Transaminase,
pubmed-meshheading:8918624-Aspartate Aminotransferases,
pubmed-meshheading:8918624-Erythropoietin,
pubmed-meshheading:8918624-Female,
pubmed-meshheading:8918624-Ferritins,
pubmed-meshheading:8918624-Hepatitis C,
pubmed-meshheading:8918624-Humans,
pubmed-meshheading:8918624-Interferon-alpha,
pubmed-meshheading:8918624-Iron,
pubmed-meshheading:8918624-Kidney Failure, Chronic,
pubmed-meshheading:8918624-Liver,
pubmed-meshheading:8918624-Male,
pubmed-meshheading:8918624-Middle Aged,
pubmed-meshheading:8918624-Recombinant Proteins,
pubmed-meshheading:8918624-Renal Dialysis
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.
|
|
pubmed:affiliation |
Servicio de Nefrología, Fundación Jiménez Díaz, Madrid, Spain.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
